In Response
- PMID: 33858004
- DOI: 10.1213/ANE.0000000000005475
In Response
Conflict of interest statement
Conflicts of Interest: S. M. Frank has served on scientific advisory boards for Baxter, Haemonetics and Medtronic. M. M. Bembea’s institution received funding for ECMO-related research from the National Institute of Neurological Disorders and Stroke (R01NS106292) and from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD096389).
Comment on
-
Blood Utilization and Clinical Outcomes in Extracorporeal Membrane Oxygenation Patients.Anesth Analg. 2020 Sep;131(3):901-908. doi: 10.1213/ANE.0000000000004807. Anesth Analg. 2020. PMID: 32304461 Free PMC article.
-
Blood Products During Extracorporeal Membrane Oxygenation: Why and How to Use?Anesth Analg. 2021 May 1;132(5):e85. doi: 10.1213/ANE.0000000000005474. Anesth Analg. 2021. PMID: 33858003 No abstract available.
References
-
- Jin Y, Liu J. Blood products during extracorporeal membrane oxygenation: why and how to use? Anesth Analg. 2021;132:e85.
-
- Qin CX, Yesantharao LV, Merkel KR, et al. Blood utilization and clinical outcomes in extracorporeal membrane oxygenation patients. Anesth Analg. 2020;131:901–908.
-
- Frank SM, Savage WJ, Rothschild JA, et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology. 2012;117:99–106.
-
- Bembea MM, Annich G, Rycus P, Oldenburg G, Berkowitz I, Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med. 2013;14:e77–e84.
-
- Smith A, Hardison D, Bridges B, Pietsch J. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion. 2013;28:54–60.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
